Skip to main content
SpringerLink
Log in

Sexual and Reproductive Health Concerns

  • Chapter
  • First Online:
Common Issues in Breast Cancer Survivors

  • 679 Accesses

Abstract

Sexual and reproductive health are important and valued aspects of a woman’s health and well-being and can be profoundly impacted by breast cancer diagnosis and treatments. For breast cancer survivors, sexual and reproductive health changes are associated with significant emotional distress and often negatively impact women’s emotional well-being, relationships, sense of self, and overall quality of life. In order to guide psychoeducation and normalization of sexual health problems, this chapter provides information regarding female sexual response and the impacts of breast cancer treatments on sexual function. Additionally, with the purpose of guiding proper evaluation, assessment, and treatment of sexual problems, latter sections include approaches for assessment and evaluation of sexual problems and strategies for managing sexual problems. Lastly, as many breast cancer treatments can adversely affect fertility, essential information regarding these effects and common methods for managing fertility concerns are provided.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organization. Defining sexual health: report of a technical consultation on sexual health, 28–31 January 2002, Geneva. Geneva, Switzerland. 2006.

    Google Scholar 

  2. Katz A. Breast cancer and women's sexuality. Am J Nurs. 2011;111(4):63–7.

    Article  PubMed  Google Scholar 

  3. Bredart A, Dolbeault S, Savignoni A, et al. Prevalence and associated factors of sexual problems after early-stage breast cancer treatment: results of a French exploratory survey. Psychooncology. 2011;20(8):841–50.

    Article  PubMed  Google Scholar 

  4. Boehmer U, Ozonoff A, Timm A, Winter M, Potter J. After breast cancer: sexual functioning of sexual minority survivors. J Sex Res. 2014;51(6):681–9.

    Article  PubMed  Google Scholar 

  5. Boquiren VM, Esplen MJ, Wong J, Toner B, Warner E, Malik N. Sexual functioning in breast cancer survivors experiencing body image disturbance. Psychooncology. 2016;25(1):66–76.

    Article  PubMed  Google Scholar 

  6. Lee M, Kim YH, Jeon MJ. Risk factors for negative impacts on sexual activity and function in younger breast cancer survivors. Psychooncology. 2015;24(9):1097–103.

    Article  CAS  PubMed  Google Scholar 

  7. Safarinejad MR, Shafiei N, Safarinejad S. Quality of life and sexual functioning in young women with early-stage breast cancer 1 year after lumpectomy. Psychooncology. 2013;22(6):1242–8.

    Article  PubMed  Google Scholar 

  8. Schover LR, Baum GP, Fuson LA, Brewster A, Melhem-Bertrandt A. Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors. J Sex Med. 2014;11(12):3102–11.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Raggio GA, Butryn ML, Arigo D, Mikorski R, Palmer SC. Prevalence and correlates of sexual morbidity in long-term breast cancer survivors. Psychol Health. 2014;29(6):632–50.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Male DA, Fergus KD, Cullen K. Sexual identity after breast cancer: sexuality, body image, and relationship repercussions. Curr Opin Support Palliat Care. 2016;10(1):66–74.

    Article  PubMed  Google Scholar 

  11. Lambertini M, Ginsburg ES, Partridge AH. Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy. Curr Opin Obstet Gynecol. 2015;27(1):98–107.

    Article  PubMed  Google Scholar 

  12. Sadovsky R, Basson R, Krychman M, et al. Cancer and sexual problems. J Sex Med. 2010;7(1 Pt 2):349–73.

    Article  PubMed  Google Scholar 

  13. Zhou ES, Frederick NN, Bober SL. Hormonal changes and sexual dysfunction. Med Clin North Am. 2017;101(6):1135–50.

    Article  PubMed  Google Scholar 

  14. Bober SL, Reese JB, Barbera L, et al. How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer. Curr Opin Support Palliat Care. 2016;10(1):44–54.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Sanchez Varela V, Zhou ES, Bober SL. Management of sexual problems in cancer patients and survivors. Curr Probl Cancer. 2013;37(6):319–52.

    Article  PubMed  Google Scholar 

  16. Thomas HN, Thurston RC. A biopsychosocial approach to women's sexual function and dysfunction at midlife: a narrative review. Maturitas. 2016;87:49–60.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Basson R. Human sexual response. In: Handbook of clinical neurology, vol. 130. Edinburgh: Elsevier; 2015. p. 11–8.

    Google Scholar 

  18. Kaplan HS. Disorders of sexual desire and other new concepts and techniques in sex therapy, vol. 2. New York: Bruner Meisel U; 1979.

    Google Scholar 

  19. Masters WH, Johnson VE. Human sexual response. Bronx: Ishi Press International; 1966.

    Google Scholar 

  20. Ussher JM, Perz J, Gilbert E. Changes to sexual Well-being and intimacy after breast cancer. Cancer Nurs. 2012;35(6):456–65.

    Article  PubMed  Google Scholar 

  21. Lewis PE, Sheng M, Rhodes MM, Jackson KE, Schover LR. Psychosocial concerns of young African American breast cancer survivors. J Psychosoc Oncol. 2012;30(2):168–84.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Quintard B, Constant A, Lakdja F, Labeyrie-Lagardere H. Factors predicting sexual functioning in patients 3 months after surgical procedures for breast cancer: the role of the sense of coherence. Eur J Oncol Nurs. 2014;18(1):41–5.

    Article  PubMed  Google Scholar 

  23. Andrzejczak E, Markocka-Maczka K, Lewandowski A. Partner relationships after mastectomy in women not offered breast reconstruction. Psychooncology. 2013;22(7):1653–7.

    Article  PubMed  Google Scholar 

  24. Gilbert E, Ussher JM, Perz J. Sexuality after breast cancer: a review. Maturitas. 2010;66(4):397–407.

    Article  PubMed  Google Scholar 

  25. Bancroft J, Graham CA, Janssen E, Sanders SA. The dual control model: current status and future directions. J Sex Res. 2009;46(2–3):121–42.

    Article  PubMed  Google Scholar 

  26. Nagoski E. Come as you are: the surprising new science that will transform your sex life. New York: Simon and Schuster; 2015.

    Google Scholar 

  27. Schlenz I, Kuzbari R, Gruber H, Holle J. The sensitivity of the nipple-areola complex: an anatomic study. Plast Reconstr Surg. 2000;105(3):905–9.

    Article  CAS  PubMed  Google Scholar 

  28. Wilmoth MC. The aftermath of breast cancer: an altered sexual self. Cancer Nurs. 2001;24(4):278–86.

    Article  CAS  PubMed  Google Scholar 

  29. Girgis A, Stacey F, Lee T, Black D, Kilbreath S. Priorities for women with lymphoedema after treatment for breast cancer: population based cohort study. BMJ. 2011;342:d3442.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Emilee G, Ussher JM, Perz J. Sexuality after breast cancer: a review. Maturitas. 2010;66(4):397–407.

    Article  PubMed  Google Scholar 

  31. Pillai-Friedman S, Ashline JL. Women, breast cancer survivorship, sexual losses, and disenfranchised grief - a treatment model for clinicians. Sex Relatsh Ther. 2014;29(4):436–53.

    Article  Google Scholar 

  32. Kiebert GM, de Haes JC, van de Velde CJ. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol. 1991;9(6):1059–70.

    Article  CAS  PubMed  Google Scholar 

  33. Markopoulos C, Tsaroucha AK, Kouskos E, Mantas D, Antonopoulou Z, Karvelis S. Impact of breast cancer surgery on the self-esteem and sexual life of female patients. J Int Med Res. 2009;37(1):182–8.

    Article  CAS  PubMed  Google Scholar 

  34. Aerts L, Christiaens MR, Enzlin P, Neven P, Amant F. Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: a prospective controlled study. Breast. 2014;23(5):629–36.

    Article  CAS  PubMed  Google Scholar 

  35. Falk SJ, Dizon DS. Sexual dysfunction in women with cancer. Fertil Steril. 2013;100(4):916–21.

    Article  PubMed  Google Scholar 

  36. Choi EK, Kim IR, Chang O, et al. Impact of chemotherapy-induced alopecia distress on body image, psychosocial Well-being, and depression in breast cancer patients. Psychooncology. 2014;23(10):1103–10.

    Article  PubMed  Google Scholar 

  37. DeSimone M, Spriggs E, Gass JS, Carson SA, Krychman ML, Dizon DS. Sexual dysfunction in female cancer survivors. Am J Clin Oncol. 2014;37(1):101–6.

    Article  PubMed  Google Scholar 

  38. Lemieux J, Maunsell E, Provencher L. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology. 2008;17(4):317–28.

    Article  PubMed  Google Scholar 

  39. Bober SL, Varela VS. Sexuality in adult cancer survivors: challenges and intervention. J Clin Oncol. 2012;30(30):3712–9.

    Article  PubMed  Google Scholar 

  40. Howard-Anderson J, Ganz PA, Bower JE, Stanton AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst. 2012;104(5):386–405.

    Article  PubMed  Google Scholar 

  41. Ochsenkuhn R, Hermelink K, Clayton AH, et al. Menopausal status in breast cancer patients with past chemotherapy determines long-term hypoactive sexual desire disorder. J Sex Med. 2011;8(5):1486–94.

    Article  PubMed  Google Scholar 

  42. Rosenberg SM, Partridge AH. Premature menopause in young breast cancer: effects on quality of life and treatment interventions. J Thorac Dis. 2013;5(Suppl 1):S55–61.

    PubMed  PubMed Central  Google Scholar 

  43. Anchan RM, Ginsburg ES. Fertility concerns and preservation in younger women with breast cancer. Crit Rev Oncol Hematol. 2010;74(3):175–92.

    Article  PubMed  Google Scholar 

  44. Farthmann J, Hanjalic-Beck A, Veit J, et al. The impact of chemotherapy for breast cancer on sexual function and health-related quality of life. Support Care Cancer. 2016;24(6):2603–9.

    Article  PubMed  Google Scholar 

  45. Schover LR. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol. 2008;26(5):753–8.

    Article  PubMed  Google Scholar 

  46. Biglia N, Bounous VE, D'Alonzo M, et al. Vaginal atrophy in breast cancer survivors: attitude and approaches among oncologists. Clin Breast Cancer. 2017;17(8):611–7.

    Article  PubMed  Google Scholar 

  47. Nappi RE, Kokot-Kierepa M. Vaginal health: insights, views & attitudes (VIVA) - results from an international survey. Climacteric. 2012;15(1):36–44.

    Article  CAS  PubMed  Google Scholar 

  48. Ussher JM, Perz J, Gilbert E. Information needs associated with changes to sexual Well-being after breast cancer. J Adv Nurs. 2013;69(2):327–37.

    Article  PubMed  Google Scholar 

  49. Burstein HJ, Lacchetti C, Anderson H, et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol. 2019;37(5):423–38.

    Article  CAS  PubMed  Google Scholar 

  50. Baumgart J, Nilsson K, Evers AS, Kallak TK, Poromaa IS. Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause. 2013;20(2):162–8.

    Article  PubMed  Google Scholar 

  51. Sears CS, Robinson JW, Walker LM. A comprehensive review of sexual health concerns after cancer treatment and the biopsychosocial treatment options available to female patients. Eur J Cancer Care (Engl). 2018;27(2):e12738.

    Article  Google Scholar 

  52. Ljungman L, Ahlgren J, Petersson LM, et al. Sexual dysfunction and reproductive concerns in young women with breast cancer: type, prevalence, and predictors of problems. Psychooncology. 2018;27(12):2770–7.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Mok K, Juraskova I, Friedlander M. The impact of aromatase inhibitors on sexual functioning: current knowledge and future research directions. Breast. 2008;17(5):436–40.

    Article  PubMed  Google Scholar 

  54. Cardoso F, Loibl S, Pagani O, et al. The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer. 2012;48(18):3355–77.

    Article  PubMed  Google Scholar 

  55. Baumgart J, Nilsson K, Stavreus-Evers A, et al. Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer. Am J Obstet Gynecol. 2011;204(1):26 e21–7.

    Article  Google Scholar 

  56. Cella D, Fallowfield L, Barker P, et al. Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer. Breast Cancer Res Treat. 2006;100(3):273–84.

    Article  PubMed  Google Scholar 

  57. Potter JE, Moore KA. Lichen sclerosus in a breast cancer survivor on an aromatase inhibitor: a case report. J Gen Intern Med. 2013;28(4):592–5.

    Article  PubMed  Google Scholar 

  58. Funaro D. Lichen sclerosus: a review and practical approach. Dermatol Ther. 2004;17(1):28–37.

    Article  PubMed  Google Scholar 

  59. Ribi K, Luo W, Bernhard J, et al. Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: patient-reported outcomes in the suppression of ovarian function trial. J Clin Oncol. 2016;34(14):1601–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Portman DJ, Gass ML, Vulvovaginal Atrophy Terminology Consensus Conference P. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Maturitas. 2014;79(3):349–54.

    Article  CAS  PubMed  Google Scholar 

  61. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: survivorship version 2.2020. NCCN2020.

    Google Scholar 

  62. Annon JS. The PLISSIT model: a proposed conceptual scheme for the behavioral treatment of sexual problems. J Sex Educ Ther. 1976;2(1):1–15.

    Article  Google Scholar 

  63. Mick J, Hughes M, Cohen MZ. Using the BETTER model to assess sexuality. Clin J Oncol Nurs. 2004;8(1):84–6.

    Article  PubMed  Google Scholar 

  64. Bakewell RT, Volker DL. Sexual dysfunction related to the treatment of young women with breast cancer. Clin J Oncol Nurs. 2005;9(6):697–702.

    Article  PubMed  Google Scholar 

  65. Dow J, Kennedy SL. Breast cancer survivors and sexuality: a review of the literature concerning sexual functioning, assessment tools, and evidence-based interventions. Clin J Oncol Nurs. 2015;19(4):456–61.

    Article  PubMed  Google Scholar 

  66. Carter J, Stabile C, Seidel B, Baser RE, Goldfarb S, Goldfrank DJ. Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors. J Cancer Surviv. 2017;11(2):274–83.

    Article  PubMed  Google Scholar 

  67. Santos-Iglesias P, Mohamed B, Walker LM. A systematic review of sexual distress measures. J Sex Med. 2018;15(5):625–44.

    Article  PubMed  Google Scholar 

  68. Hatzichristou D, Rosen RC, Broderick G, et al. Clinical evaluation and management strategy for sexual dysfunction in men and women. J Sex Med. 2004;1(1):49–57.

    Article  PubMed  Google Scholar 

  69. Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208.

    Article  CAS  PubMed  Google Scholar 

  70. Baser RE, Li Y, Carter J. Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors. Cancer. 2012;118(18):4606–18.

    Article  PubMed  Google Scholar 

  71. Bartula I, Sherman KA. Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations. Breast Cancer Res Treat. 2013;141(2):173–85.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Flynn KE, Lin L, Cyranowski JM, et al. Development of the NIH PROMIS (R) sexual function and satisfaction measures in patients with cancer. J Sex Med. 2013;10(Suppl 1):43–52.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  73. Flynn KE, Reeve BB, Lin L, Cyranowski JM, Bruner DW, Weinfurt KP. Construct validity of the PROMIS(R) sexual function and satisfaction measures in patients with cancer. Health Qual Life Outcomes. 2013;11:40.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Weinfurt KP, Lin L, Bruner DW, et al. Development and initial validation of the PROMIS((R)) sexual function and satisfaction measures version 2.0. J Sex Med. 2015;12(9):1961–74.

    Article  PubMed  Google Scholar 

  75. Clayton AH, Groth J. Etiology of female sexual dysfunction. Womens Health (Lond). 2013;9(2):135–7.

    Article  CAS  PubMed  Google Scholar 

  76. Faubion SS, Rullo JE. Sexual dysfunction in women: a practical approach. Am Fam Physician. 2015;92(4):281–8.

    PubMed  Google Scholar 

  77. Szabo RA, Marino JL, Hickey M. Managing menopausal symptoms after cancer. Climacteric. 2019;22(6):572–8.

    Article  CAS  PubMed  Google Scholar 

  78. Basson R. Sexual function of women with chronic illness and cancer. Womens Health (Lond). 2010;6(3):407–29.

    Article  Google Scholar 

  79. Kingsberg SA, Rezaee RL. Hypoactive sexual desire in women. Menopause. 2013;20(12):1284–300.

    Article  PubMed  Google Scholar 

  80. Faubion SS, Larkin LC, Stuenkel CA, et al. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health. Menopause. 2018;25(6):596–608.

    Article  PubMed  Google Scholar 

  81. Iverson KM, McLaughlin KA, Gerber MR, et al. Exposure to interpersonal violence and its associations with psychiatric morbidity in a U.S. National Sample: a gender comparison. Psychol Violence. 2013;3(3):273–87.

    Article  PubMed  PubMed Central  Google Scholar 

  82. World Health Organization. Violence against women: A global health problem of epidemic proportions. http://www.who.int/mediacentre/news/releases/2013/violence_against_women_20130620/en/2013.

  83. Ackerson K. A history of interpersonal trauma and the gynecological exam. Qual Health Res. 2012;22(5):679–88.

    Article  PubMed  Google Scholar 

  84. Huber JD, Pukall CF, Boyer SC, Reissing ED, Chamberlain SM. "Just relax": physicians' experiences with women who are difficult or impossible to examine gynecologically. J Sex Med. 2009;6(3):791–9.

    Article  PubMed  Google Scholar 

  85. Schnur JB, Dillon MJ, Goldsmith RE, Montgomery GH. Cancer treatment experiences among survivors of childhood sexual abuse: a qualitative investigation of triggers and reactions to cumulative trauma. Palliat Support Care. 2018;16(6):767–76.

    Article  PubMed  Google Scholar 

  86. Ades V. The trauma-informed examination. In: Ades V, editor. Sexual and gender-based violence: a complete clinical guide. Cham: Springer International Publishing; 2020. p. 129–46.

    Chapter  Google Scholar 

  87. Latif EZ, Diamond MP. Arriving at the diagnosis of female sexual dysfunction. Fertil Steril. 2013;100(4):898–904.

    Article  PubMed  Google Scholar 

  88. Krychman ML, Katz A. Breast cancer and sexuality: multi-modal treatment options. J Sex Med. 2012;9(1):5–13; quiz 14-15.

    Article  CAS  PubMed  Google Scholar 

  89. Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society. Menopause. 2013;20(9):888–902; quiz 903-884.

    Google Scholar 

  90. Carter J, Goldfrank D, Schover LR. Simple strategies for vaginal health promotion in cancer survivors. J Sex Med. 2011;8(2):549–59.

    Article  PubMed  Google Scholar 

  91. Edwards D, Panay N. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? Climacteric. 2016;19(2):151–61.

    Article  CAS  PubMed  Google Scholar 

  92. Mitchell CM, Guthrie KA, Larson J, et al. Sexual frequency and pain in a randomized clinical trial of vaginal estradiol tablets, moisturizer, and placebo in postmenopausal women. Menopause. 2019;26(8):816–22.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Mitchell CM, Reed SD, Diem S, et al. Efficacy of vaginal estradiol or vaginal moisturizer vs placebo for treating postmenopausal vulvovaginal symptoms: a randomized clinical trial. JAMA Intern Med. 2018;178(5):681–90.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Brown JM, Hess KL, Brown S, Murphy C, Waldman AL, Hezareh M. Intravaginal practices and risk of bacterial vaginosis and candidiasis infection among a cohort of women in the United States. Obstet Gynecol. 2013;121(4):773–80.

    Article  PubMed  Google Scholar 

  95. Ayehunie S, Wang YY, Landry T, Bogojevic S, Cone RA. Hyperosmolal vaginal lubricants markedly reduce epithelial barrier properties in a three-dimensional vaginal epithelium model. Toxicol Rep. 2018;5:134–40.

    Article  CAS  PubMed  Google Scholar 

  96. Potter N, Panay N. Vaginal lubricants and moisturizers: a review into use, efficacy, and safety. Climacteric. 2021;24(1):19–24. https://doi.org/10.1080/13697137.2020.1820478. Epub 2020 Sep 29. PMID: 32990054.

  97. Jokar A, Davari T, Asadi N, Ahmadi F, Foruhari S. Comparison of the hyaluronic acid vaginal cream and conjugated estrogen used in treatment of vaginal atrophy of menopause women: a randomized controlled clinical trial. Int J Community Based Nurs Midwifery. 2016;4(1):69–78.

    PubMed  PubMed Central  Google Scholar 

  98. Chen J, Geng L, Song X, Li H, Giordan N, Liao Q. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial. J Sex Med. 2013;10(6):1575–84.

    Article  CAS  PubMed  Google Scholar 

  99. Stute P. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief? Arch Gynecol Obstet. 2013;288(6):1199–201.

    Article  PubMed  Google Scholar 

  100. Carter J, Goldfarb S, Baser RE, et al. A single-arm clinical trial investigating the effectiveness of a non-hormonal, hyaluronic acid-based vaginal moisturizer in endometrial cancer survivors. Gynecol Oncol. 2020;158(2):366–74. https://doi.org/10.1016/j.ygyno.2020.05.025. Epub 2020 Jun 8. PMID: 32522420. PMCID: PMC7423634.

  101. Carter J, Baser RE, Goldfrank DJ, et al. A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors. Support Care Cancer. 2020.

    Google Scholar 

  102. Advani P, Brewster AM, Baum GP, Schover LR. A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy. J Cancer Surviv. 2017;11(4):477–85.

    Article  PubMed  Google Scholar 

  103. Rubin ES, Deshpande NA, Vasquez PJ, Kellogg SS. A clinical reference guide on sexual devices for obstetrician-gynecologists. Obstet Gynecol. 2019;133(6):1259–68.

    Article  PubMed  Google Scholar 

  104. Capobianco G, Donolo E, Borghero G, Dessole F, Cherchi PL, Dessole S. Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women. Arch Gynecol Obstet. 2012;285(2):397–403.

    Article  PubMed  Google Scholar 

  105. Faubion SS, Shuster LT, Bharucha AE. Recognition and management of nonrelaxing pelvic floor dysfunction. Mayo Clin Proc. 2012;87(2):187–93.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Bakker RM, Vermeer WM, Creutzberg CL, Mens JW, Nout RA, Ter Kuile MM. Qualitative accounts of patients' determinants of vaginal dilator use after pelvic radiotherapy. J Sex Med. 2015;12(3):764–73.

    Article  PubMed  Google Scholar 

  107. Bakker RM, ter Kuile MM, Vermeer WM, et al. Sexual rehabilitation after pelvic radiotherapy and vaginal dilator use: consensus using the Delphi method. Int J Gynecol Cancer. 2014;24(8):1499–506.

    Article  PubMed  Google Scholar 

  108. Bernard S, Ouellet MP, Moffet H, Roy JS, Dumoulin C. Effects of radiation therapy on the structure and function of the pelvic floor muscles of patients with cancer in the pelvic area: a systematic review. J Cancer Surviv. 2016;10(2):351–62.

    Article  PubMed  Google Scholar 

  109. Rosenbaum TY. Physiotherapy treatment of sexual pain disorders. J Sex Marital Ther. 2005;31(4):329–40.

    Article  PubMed  Google Scholar 

  110. Pumo V, Milone G, Iacono M, et al. Psychological and sexual disorders in long-term breast cancer survivors. Cancer Manag Res. 2012;4:61–5.

    PubMed  PubMed Central  Google Scholar 

  111. Yang EJ, Lim JY, Rah UW, Kim YB. Effect of a pelvic floor muscle training program on gynecologic cancer survivors with pelvic floor dysfunction: a randomized controlled trial. Gynecol Oncol. 2012;125(3):705–11.

    Article  PubMed  Google Scholar 

  112. Cacciari LP, Dumoulin C, Hay-Smith EJ. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women: a cochrane systematic review abridged republication. Braz J Phys Ther. 2019;23(2):93–107.

    Article  PubMed  PubMed Central  Google Scholar 

  113. Juraskova I, Jarvis S, Mok K, et al. The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer. J Sex Med. 2013;10(10):2549–58.

    Article  PubMed  Google Scholar 

  114. Rutledge TL, Rogers R, Lee SJ, Muller CY. A pilot randomized control trial to evaluate pelvic floor muscle training for urinary incontinence among gynecologic cancer survivors. Gynecol Oncol. 2014;132(1):154–8.

    Article  PubMed  Google Scholar 

  115. Marsh S, Borges VF, Coons HL, Afghahi A. Sexual health after a breast cancer diagnosis in young women: clinical implications for patients and providers. Breast Cancer Res Treat. 2020;184(3):655–63. https://doi.org/10.1007/s10549-020-05880-3. Epub 2020 Sep 23. PMID: 32968951.

  116. Carter J, Lacchetti C, Andersen BL, et al. Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline. J Clin Oncol. 2018;36(5):492–511.

    Article  PubMed  Google Scholar 

  117. Ramanathan V, Redelman M. Sexual dysfunctions and sex therapy: the role of a general practitioner. Aust J Gen Pract. 2020;49(7):412–5.

    Article  PubMed  Google Scholar 

  118. Brotto LA, Heiman JR, Goff B, et al. A psychoeducational intervention for sexual dysfunction in women with gynecologic cancer. Arch Sex Behav. 2008;37(2):317–29.

    Article  PubMed  Google Scholar 

  119. Brotto LA, Erskine Y, Carey M, et al. A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer. Gynecol Oncol. 2012;125(2):320–5.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Caldwell R, Classen C. Lagana' L, et al. changes in sexual functioning and mood among women treated for gynecological cancer who receive group therapy: a pilot study. J Clin Psychol Med Settings. 2003;10(3):149–56.

    Article  Google Scholar 

  121. Scott JL, Halford WK, Ward BG. United we stand? The effects of a couple-coping intervention on adjustment to early stage breast or gynecological cancer. J Consult Clin Psychol. 2004;72(6):1122–35.

    Article  PubMed  Google Scholar 

  122. Scott JL, Kayser K. A review of couple-based interventions for enhancing women's sexual adjustment and body image after cancer. Cancer J (Sudbury, Mass). 2009;15(1):48–56.

    Article  Google Scholar 

  123. Derzko C, Elliott S, Lam W. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr Oncol. 2007;14(Suppl 1):S20–40.

    Article  PubMed  PubMed Central  Google Scholar 

  124. DuHamel K, Schuler T, Nelson C, et al. The sexual health of female rectal and anal cancer survivors: results of a pilot randomized psycho-educational intervention trial. J Cancer Surviv. 2016;10(3):553–63.

    Article  PubMed  Google Scholar 

  125. Hummel SB, van Lankveld J, Oldenburg HSA, et al. Efficacy of internet-based cognitive behavioral therapy in improving sexual functioning of breast cancer survivors: results of a randomized controlled trial. J Clin Oncol. 2017;35(12):1328–40.

    Article  PubMed  Google Scholar 

  126. Reese JB, Porter LS, Casale KE, et al. Adapting a couple-based intimacy enhancement intervention to breast cancer: a developmental study. Health Psychol. 2016;35(10):1085–96.

    Article  PubMed  PubMed Central  Google Scholar 

  127. Rowland JH, Meyerowitz BE, Crespi CM, et al. Addressing intimacy and partner communication after breast cancer: a randomized controlled group intervention. Breast Cancer Res Treat. 2009;118(1):99–111.

    Article  PubMed  PubMed Central  Google Scholar 

  128. Schover LR, Yuan Y, Fellman BM, Odensky E, Lewis PE, Martinetti P. Efficacy trial of an internet-based intervention for cancer-related female sexual dysfunction. J Natl Compr Cancer Netw. 2013;11(11):1389–97.

    Article  Google Scholar 

  129. Goetsch MF, Lim JY, Caughey AB. A practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2015;33(30):3394–400.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  130. American College of O, Gynecologists' Committee on Gynecologic P, Farrell R. ACOG Committee opinion no. 659: the use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. Obstet Gynecol. 2016;127(3):e93–6.

    Article  Google Scholar 

  131. Martel C, Labrie F, Archer DF, et al. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks. J Steroid Biochem Mol Biol. 2016;159:142–53.

    Article  CAS  PubMed  Google Scholar 

  132. Barton DL, Shuster LT, Dockter T, et al. Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance). Support Care Cancer. 2018;26(4):1335–43.

    Article  PubMed  Google Scholar 

  133. Barton DL, Sloan JA, Shuster LT, et al. Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance). Support Care Cancer. 2018;26(2):643–50.

    Article  PubMed  Google Scholar 

  134. Witherby S, Johnson J, Demers L, et al. Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study. Oncologist. 2011;16(4):424–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  135. Dahir M, Travers-Gustafson D. Breast cancer, aromatase inhibitor therapy, and sexual functioning: a pilot study of the effects of vaginal testosterone therapy. Sex Med. 2014;2(1):8–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  136. Melisko ME, Goldman ME, Hwang J, et al. Vaginal testosterone cream vs estradiol vaginal ring for vaginal dryness or decreased libido in women receiving aromatase inhibitors for early-stage breast cancer: a randomized clinical trial. JAMA Oncol. 2017;3(3):313–9.

    Article  PubMed  Google Scholar 

  137. Mirkin S, Pickar JH. Selective estrogen receptor modulators (SERMs): a review of clinical data. Maturitas. 2015;80(1):52–7.

    Article  CAS  PubMed  Google Scholar 

  138. Clemons M, Danson S, Howell A. Tamoxifen ("Nolvadex"): a review. Cancer Treat Rev. 2002;28(4):165–80.

    Article  CAS  PubMed  Google Scholar 

  139. Assikis VJ, Jordan VC. Risks and benefits of tamoxifen therapy. [Review] [13 refs]. Oncology. 1997;11(2 Suppl 1):21.

    CAS  PubMed  Google Scholar 

  140. Robinson E, Kimmick GG, Muss HB. Tamoxifen in postmenopausal women a safety perspective. Drugs Aging. 1996;8(5):329–37.

    Article  CAS  PubMed  Google Scholar 

  141. Pinkerton JV, Stanczyk FZ. Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy. Menopause. 2014;21(3):309–19.

    Article  PubMed  Google Scholar 

  142. Bachmann GA, Komi JO, Ospemifene SG. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study. Menopause. 2010;17(3):480–6.

    Article  PubMed  Google Scholar 

  143. Hillard TC. Lasers in the era of evidence-based medicine. Climacteric. 2020;23(sup1):S6–S10.

    Article  CAS  PubMed  Google Scholar 

  144. Mounir DM, Hernandez N, Gonzalez RR. Update: the clinical role of vaginal lasers for the treatment of the genitourinary syndrome of menopause. Urology. 2021;151:2–7. https://doi.org/10.1016/j.urology.2020.09.012. Epub 2020 Sep 20. PMID: 32966821.

  145. Pagano T, De Rosa P, Vallone R, et al. Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study. Menopause. 2016;23(10):1108–13.

    Article  PubMed  Google Scholar 

  146. Becorpi A, Campisciano G, Zanotta N, et al. Fractional CO2 laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects. Lasers Med Sci. 2018;33(5):1047–54.

    Article  PubMed  Google Scholar 

  147. Gambacciani M, Levancini M. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors. Menopause. 2017;24(3):316–9.

    Article  PubMed  Google Scholar 

  148. Taylor MJ, Rudkin L, Bullemor-Day P, Lubin J, Chukwujekwu C, Hawton K. Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev. 2013;5:CD003382.

    Google Scholar 

  149. Carroll FI, Blough BE, Mascarella SW, Navarro HA, Lukas RJ, Damaj MI. Bupropion and bupropion analogs as treatments for CNS disorders. Adv Pharmacol. 2014;69:177–216.

    Article  CAS  PubMed  Google Scholar 

  150. Segraves RT, Clayton A, Croft H, Wolf A, Warnock J. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol. 2004;24(3):339–42.

    Article  CAS  PubMed  Google Scholar 

  151. Safarinejad MR, Hosseini SY, Asgari MA, Dadkhah F, Taghva A. A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women. BJU Int. 2010;106(6):832–9.

    Article  CAS  PubMed  Google Scholar 

  152. Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 2004;65(1):62–7.

    Article  CAS  PubMed  Google Scholar 

  153. Mathias C, Cardeal Mendes CM, Ponde de Sena E, et al. An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer. Ann Oncol. 2006;17(12):1792–6.

    Article  CAS  PubMed  Google Scholar 

  154. Mayer SE, Weiss NS, Chubak J, et al. CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy. Cancer Causes Control. 2019;30(1):103–12.

    Article  PubMed  Google Scholar 

  155. Kingsberg SA, Simon JA. Female hypoactive sexual desire disorder: a practical guide to causes, clinical diagnosis, and treatment. J Womens Health (Larchmt). 2020;29(8):1101–12.

    Article  Google Scholar 

  156. Stahl SM. Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder. CNS Spectr. 2015;20(1):1–6.

    Article  PubMed  Google Scholar 

  157. Mayer D, Lynch SE. Bremelanotide: new drug approved for treating hypoactive sexual desire disorder. Ann Pharmacother. 2020;54(7):684–90.

    Article  CAS  PubMed  Google Scholar 

  158. Chivers ML, Rosen RC. Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms? J Sex Med. 2010;7(2 Pt 2):858–72.

    Article  CAS  PubMed  Google Scholar 

  159. Therapeutic Research Faculty. Natural medicines comprehensive database consumer version [Internet]. https://medlineplus.gov/druginfo. 2020.

  160. National Center for Complementary and Integrative Health. Herbs at a glance. https://www.nccih.nih.gov/health/herbsataglance. 2020.

  161. Memorial Sloan Kettering Cancer Center. About herbs, botanicals, and other products. https://www.mskcc.org/cancer-care/diagnosis-treatment/symptom-management/integrative-medicine/herbs. 2020.

  162. Oktay K, Harvey BE, Partridge AH, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994–2001.

    Article  PubMed  Google Scholar 

  163. ACOG Committee opinion no. 747 summary: gynecologic issues in children and adolescent cancer patients and survivors. Obstet Gynecol. 2018;132(2):535–6.

    Google Scholar 

  164. ACOG: committee opinion no. 584: oocyte cryopreservation. Obstet Gynecol. 2014;123(1):221–2.

    Google Scholar 

  165. Ethics Committee of American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertil Steril. 2013;100(5):1224–31.

    Article  Google Scholar 

  166. National Comprehensive Cancer Network. National comprehensive cancer center clinical practice guidelines in oncology (NCCN Guidelines): adolescent and young adult (AYA) oncology. 2019; Version 1.2020:https://www.nccn.org/professionals/physician_gls/pdf/aya.pdf.

  167. Paluch-Shimon S, Pagani O, Partridge AH, et al. ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3). Breast. 2017;35:203–17.

    Article  PubMed  Google Scholar 

  168. Lambertini M, Anserini P, Levaggi A, Poggio F, Del Mastro L. Fertility counseling of young breast cancer patients. J Thorac Dis. 2013;5 Suppl 1(Suppl 1):S68–80.

    PubMed  Google Scholar 

  169. Logan S, Perz J, Ussher JM, Peate M, Anazodo A. Systematic review of fertility-related psychological distress in cancer patients: informing on an improved model of care. Psychooncology. 2019;28(1):22–30.

    Article  PubMed  Google Scholar 

  170. Hammond C, Abrams JR, Syrjala KL. Fertility and risk factors for elevated infertility concern in 10-year hematopoietic cell transplant survivors and case-matched controls. J Clin Oncol. 2007;25(23):3511–7.

    Article  PubMed  Google Scholar 

  171. Canada AL, Schover LR. The psychosocial impact of interrupted childbearing in long-term female cancer survivors. Psychooncology. 2012;21(2):134–43.

    Article  PubMed  Google Scholar 

  172. Waimey KE, Smith BM, Confino R, Jeruss JS, Pavone ME. Understanding fertility in young female cancer patients. J Womens Health (Larchmt). 2015;24(10):812–8.

    Article  Google Scholar 

  173. Adrienne GW, Ann HP. Fertility preservation in patients with breast cancer: necessity, methods, and safety. J Natl Compr Canc Netw. 2016;14(3):355–63.

    Article  Google Scholar 

  174. Practice Committee of the American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112(6):1022–33.

    Article  Google Scholar 

  175. Diaz-Garcia C, Domingo J, Garcia-Velasco JA, et al. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril. 2018;109(3):478–485.e472.

    Article  PubMed  Google Scholar 

  176. Oktay K. Evidence for limiting ovarian tissue harvesting for the purpose of transplantation to women younger than 40 years of Ageb. J Clin Endocrinol Metabol. 2002;87(4):1907–8.

    Article  CAS  Google Scholar 

  177. Hudson JN, Stanley NB, Nahata L, Bowman-Curci M, Quinn GP. New promising strategies in oncofertility. Expert Rev Qual Life Cancer Care. 2017;2(2):67–78.

    Article  PubMed  PubMed Central  Google Scholar 

  178. Donnez J, Dolmans M-M. Fertility preservation in women. N Engl J Med. 2017;377(17):1657–65.

    Article  PubMed  Google Scholar 

  179. Doyle JO, Richter KS, Lim J, Stillman RJ, Graham JR, Tucker MJ. Successful elective and medically indicated oocyte vitrification and warming for autologous invitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertil Steril. 2016;105(2):459–466.e452.

    Article  PubMed  Google Scholar 

  180. Lambertini M, Richard F, Nguyen B, Viglietti G, Villarreal-Garza C. Ovarian function and fertility preservation in breast cancer: should gonadotropin-releasing hormone agonist be administered to all premenopausal patients receiving chemotherapy? Clin Med Insights Reprod Health. 2019;13:1179558119828393.

    Article  PubMed  PubMed Central  Google Scholar 

  181. Moore HCF, Unger JM, Phillips KA, et al. Final analysis of the prevention of early menopause study (POEMS)/SWOG intergroup S0230. J Natl Cancer Inst. 2019;111(2):210–3.

    Article  PubMed  Google Scholar 

  182. Azim HA Jr, Kroman N, Paesmans M, et al. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study. J Clin Oncol. 2013;31(1):73–9.

    Article  PubMed  Google Scholar 

  183. Lambertini M, Kroman N, Ameye L, et al. Safety of pregnancy in patients (pts) with history of estrogen receptor positive (ER+) breast cancer (BC): long-term follow-up analysis from a multicenter study. J Clin Oncol. 2017;35(15_suppl):LBA10066.

    Article  Google Scholar 

  184. Lambertini M, Kroman N, Ameye L, et al. Long-term safety of pregnancy following breast cancer according to estrogen receptor status. JNCI: Journal of the National Cancer Institute. 2017;110(4):426–9.

    Article  PubMed Central  Google Scholar 

  185. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with Letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008;26(16):2630–5.

    Article  CAS  PubMed  Google Scholar 

  186. Kim J, Turan V, Oktay K. Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer. J Clin Endocrinol Metab. 2016;101(4):1364–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  187. Bitzer J, Giraldi A, Pfaus J. Sexual desire and hypoactive sexual desire disorder in women. Introduction and overview. Standard operating procedure (SOP Part 1). J Sex Med. 2013;10(1):36–49.

    Article  PubMed  Google Scholar 

  188. Maseroli E, Scavello I, Vignozzi L. Cardiometabolic risk and female sexuality-part I. risk factors and potential pathophysiological underpinnings for female Vasculogenic sexual dysfunction syndromes. Sex Med Rev. 2018;6(4):508–24.

    Article  PubMed  Google Scholar 

  189. Esposito K, Ciotola M, Maiorino MI, et al. Hyperlipidemia and sexual function in premenopausal women. J Sex Med. 2009;6(6):1696–703.

    Article  CAS  PubMed  Google Scholar 

  190. Maseroli E, Fanni E, Cipriani S, et al. Cardiometabolic risk and female sexuality: focus on clitoral vascular resistance. J Sex Med. 2016;13(11):1651–61.

    Article  PubMed  Google Scholar 

  191. Jaarsma T, Fridlund B, Martensson J. Sexual dysfunction in heart failure patients. Curr Heart Fail Rep. 2014;11(3):330–6.

    Article  PubMed  Google Scholar 

  192. Emami Zeydi A, Sharafkhani M, Armat MR, Gould KA, Soleimani A, Hosseini SJ. Women's sexual issues after myocardial infarction: a literature review. Dimens Crit Care Nurs. 2016;35(4):195–203.

    Article  PubMed  Google Scholar 

  193. Grenier-Genest A, Gerard M, Courtois F. Stroke and sexual functioning: a literature review. NeuroRehabilitation. 2017;41(2):293–315.

    Article  PubMed  Google Scholar 

  194. Rahmanian E, Salari N, Mohammadi M, Jalali R. Evaluation of sexual dysfunction and female sexual dysfunction indicators in women with type 2 diabetes: a systematic review and meta-analysis. Diabetol Metab Syndr. 2019;11:73.

    Article  PubMed  PubMed Central  Google Scholar 

  195. Carosa E, Sansone A, Jannini EA. Management of endocrine disease: female sexual dysfunction for the endocrinologist. Eur J Endocrinol. 2020;182(6):R101.

    Article  CAS  PubMed  Google Scholar 

  196. Di Francesco S, Caruso M, Robuffo I, Militello A, Toniato E. The impact of metabolic syndrome and its components on female sexual dysfunction: a narrative mini-review. Curr Urol. 2019;12(2):57–63.

    Article  PubMed  PubMed Central  Google Scholar 

  197. Wang Y, Wang H. Effects of hypothyroidism and subclinical hypothyroidism on sexual function: a meta-analysis of studies using the female sexual function index. Sex Med. 2020;8(2):156–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  198. Newman AM. Arthritis and sexuality. Nurs Clin North Am. 2007;42(4):621–30;vii.

    Article  PubMed  Google Scholar 

  199. Rosenbaum TY. Musculoskeletal pain and sexual function in women. J Sex Med. 2010;7(2 Pt 1):645–53.

    Article  PubMed  Google Scholar 

  200. Cook DJ, Guyatt GH, Adachi JD, et al. Quality of life issues in women with vertebral fractures due to osteoporosis. Arthritis Rheum. 1993;36(6):750–6.

    Article  CAS  PubMed  Google Scholar 

  201. Sadeghi-Nejad H, Wasserman M, Weidner W, Richardson D, Goldmeier D. Sexually transmitted diseases and sexual function. J Sex Med. 2010;7(1 Pt 2):389–413.

    Article  PubMed  Google Scholar 

  202. La Rosa VL, Ciebiera M, Lin LT, et al. Multidisciplinary management of women with pelvic organ prolapse, urinary incontinence and lower urinary tract symptoms.A clinical and psychological overview. Prz Menopauzalny. 2019;18(3):184–90.

    PubMed  PubMed Central  Google Scholar 

  203. Pluchino N, Wenger JM, Petignat P, et al. Sexual function in endometriosis patients and their partners: effect of the disease and consequences of treatment. Hum Reprod Update. 2016;22(6):762–74.

    Article  PubMed  Google Scholar 

  204. Levy G, Lowenstein L. Overactive bladder syndrome treatments and their effect on female sexual function: a review. Sex Med. 2020;8(1):1–7.

    Article  PubMed  Google Scholar 

  205. Szydlarska D, Jakubowska A, Rydzewska G. Assessment of sexual dysfunction in patients with inflammatory bowel disease. Prz Gastroenterol. 2019;14(2):104–8.

    PubMed  PubMed Central  Google Scholar 

  206. Krysko KM, Graves JS, Dobson R, et al. Sex effects across the lifespan in women with multiple sclerosis. Ther Adv Neurol Disord. 2020;13:1756286420936166.

    Article  PubMed  PubMed Central  Google Scholar 

  207. Polat Dunya C, Tulek Z, Uchiyama T, Haslam C, Panicker JN. Systematic review of the prevalence, symptomatology and management options of sexual dysfunction in women with multiple sclerosis. Neurourol Urodyn. 2020;39(1):83–95.

    Article  PubMed  Google Scholar 

  208. Meco G, Rubino A, Caravona N, Valente M. Sexual dysfunction in Parkinson's disease. Parkinsonism Relat Disord. 2008;14(6):451–6.

    Article  PubMed  Google Scholar 

  209. Oertel WH, Wachter T, Quinn NP, Ulm G, Brandstadter D. Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type. Mov Disord. 2003;18(4):430–2.

    Article  PubMed  Google Scholar 

  210. Latella D, Maggio MG, De Luca R, et al. Changes in sexual functioning following traumatic brain injury: an overview on a neglected issue. J Clin Neurosci. 2018;58:1–6.

    Article  PubMed  Google Scholar 

  211. Rathore C, Henning OJ, Luef G, Radhakrishnan K. Sexual dysfunction in people with epilepsy. Epilepsy Behav. 2019;100(Pt A):106495.

    Article  PubMed  Google Scholar 

  212. Bossini L, Fagiolini A, Valdagno M, Polizzotto NR, Castrogiovanni P. Sexual disorders in subjects treated for mood and anxiety diseases. J Clin Psychopharmacol. 2007;27(3):310–2.

    Article  PubMed  Google Scholar 

  213. Cyranowski JM, Bromberger J, Youk A, Matthews K, Kravitz HM, Powell LH. Lifetime depression history and sexual function in women at midlife. Arch Sex Behav. 2004;33(6):539–48.

    Article  PubMed  Google Scholar 

  214. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009;373(9665):746–58.

    Article  CAS  PubMed  Google Scholar 

  215. Association of Reproductive Health Professionals. Women’s sexual health in midlife and beyond. AHRP Clin Proc. 2005;5:8–12.

    Google Scholar 

  216. American Society of Health-System Pharmacists I. AHFS patient medication information database. https://medlineplus.gov/druginformation.html. 2020. Accessed 15 Oct 2020.

  217. Greven KM, Case LD, Nycum LR, et al. Effect of ArginMax on sexual functioning and quality of life among female cancer survivors: resu lts of the WFU CCOP Research Base protocol 97106. J Community Support Oncol. 2015;13(3):87–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  218. Lee MS, Shin BC, Yang EJ, Lim HJ, Ernst E. Maca (Lepidium meyenii) for treatment of menopausal symptoms: a systematic review. Maturitas. 2011;70(3):227–33.

    Article  PubMed  Google Scholar 

  219. Shin BC, Lee MS, Yang EJ, Lim HS, Ernst E. Maca (L. meyenii) for improving sexual function: a systematic review. BMC Complement Altern Med. 2010;10:44.

    Article  PubMed  PubMed Central  Google Scholar 

  220. Meacham LR, Burns K, Orwig KE, Levine J. Standardizing risk assessment for treatment-related gonadal insufficiency and infertility in childhood adolescent and young adult cancer: the pediatric initiative network risk stratification system. J Adolesc Young Adult Oncol. 2020;9(6):662–6.

    Article  PubMed  Google Scholar 

  221. Levine JM, Whitton JA, Ginsberg JP, et al. Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: a report from the childhood cancer survivor study. Cancer. 2018;124(5):1044–52.

    Article  PubMed  Google Scholar 

  222. Chemaitilly W, Mertens AC, Mitby P, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metabol. 2006;91(5):1723–8.

    Article  CAS  Google Scholar 

  223. Green DM, Nolan VG, Kawashima T, et al. Decreased fertility among female childhood cancer survivors who received 22-27 Gy hypothalamic/pituitary irradiation: a report from the childhood cancer survivor study. Fertil Steril. 2011;95(6):1922–1927.e1921.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA

    Rebecca A. Shelby

  2. Department of Psychology and Neuroscience, Duke University, Durham, NC, USA

    Jessica N. Coleman & Sarah S. Arthur

  3. Department of Obstetrics and Gynecology, Duke University, Durham, NC, USA

    Kelly S. Acharya

  4. Department of Physical Therapy and Occupational Therapy, Duke University, Durham, NC, USA

    Amanda A. Heath

  5. Department of Gynecology, Augusta Health, Fishersville, VA, USA

    Margaret D. Flather

  6. Department of Medicine, Division of Medical Oncology, Duke University, Durham, NC, USA

    Kelly E. Westbrook

  7. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA

    Caroline S. Dorfman

Authors
  1. Rebecca A. Shelby
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jessica N. Coleman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sarah S. Arthur
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kelly S. Acharya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Amanda A. Heath
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Margaret D. Flather
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kelly E. Westbrook
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Caroline S. Dorfman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rebecca A. Shelby .

Editor information

Editors and Affiliations

  1. Medical Oncology, Duke University School of Medicine/Duke Cancer Institute, Durham, NC, USA

    Gretchen G. Kimmick

  2. Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA

    Rebecca A. Shelby

  3. Duke University School of Medicine Duke Cancer Network, Durham, NC, USA

    Linda M. Sutton

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Shelby, R.A. et al. (2021). Sexual and Reproductive Health Concerns. In: Kimmick, G.G., Shelby, R.A., Sutton, L.M. (eds) Common Issues in Breast Cancer Survivors. Springer, Cham. https://doi.org/10.1007/978-3-030-75377-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-75377-1_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-75376-4

  • Online ISBN: 978-3-030-75377-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation